
Robert Stockton Jones Jr.
Examiner (ID: 3854)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1762 |
| Total Applications | 1302 |
| Issued Applications | 945 |
| Pending Applications | 17 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7454342
[patent_doc_number] => 20040068006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Method for preventing acute renal failure'
[patent_app_type] => new
[patent_app_number] => 10/679040
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3481
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679040 | Method for preventing acute renal failure | Oct 2, 2003 | Abandoned |
Array
(
[id] => 5801616
[patent_doc_number] => 20060035957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Preventive or remedy for bedsore'
[patent_app_type] => utility
[patent_app_number] => 10/529721
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7482
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529721 | Preventive or remedy for bedsore | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7674234
[patent_doc_number] => 20040127884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis'
[patent_app_type] => new
[patent_app_number] => 10/674290
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27996
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674290 | Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis | Sep 28, 2003 | Abandoned |
Array
(
[id] => 7378854
[patent_doc_number] => 20040220239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions'
[patent_app_type] => new
[patent_app_number] => 10/669251
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13002
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10669251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/669251 | Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions | Sep 24, 2003 | Abandoned |
Array
(
[id] => 7281290
[patent_doc_number] => 20040063667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phospate as active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/661580
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2503
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661580 | Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis | Sep 14, 2003 | Issued |
Array
(
[id] => 837019
[patent_doc_number] => 07393834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'LHRH-antagonists in the treatment of fertility disorders'
[patent_app_type] => utility
[patent_app_number] => 10/661780
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2835
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661780 | LHRH-antagonists in the treatment of fertility disorders | Sep 14, 2003 | Issued |
Array
(
[id] => 7468625
[patent_doc_number] => 20040053977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Medicinal uses of hydrazones'
[patent_app_type] => new
[patent_app_number] => 10/661905
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14349
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661905 | Medicinal uses of hydrazones | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7310887
[patent_doc_number] => 20040143015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Combination of organic compounds'
[patent_app_type] => new
[patent_app_number] => 10/471253
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9451
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471253
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471253 | Combination of organic compounds | Sep 9, 2003 | Abandoned |
Array
(
[id] => 7070192
[patent_doc_number] => 20050245577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Drug for kidney failure containing oxaluric acid derivative'
[patent_app_type] => utility
[patent_app_number] => 10/526527
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1812
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526527 | Drug for kidney failure containing oxaluric acid derivative | Sep 9, 2003 | Abandoned |
Array
(
[id] => 860469
[patent_doc_number] => 07371729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Boronic acid salts useful in parenteral formulations'
[patent_app_type] => utility
[patent_app_number] => 10/658971
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34592
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658971 | Boronic acid salts useful in parenteral formulations | Sep 8, 2003 | Issued |
Array
(
[id] => 7474105
[patent_doc_number] => 20040122008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Treatment of pain by inhibition of p38 MAP kinase'
[patent_app_type] => new
[patent_app_number] => 10/655745
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24734
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655745 | Treatment of pain by inhibition of p38 MAP kinase | Sep 4, 2003 | Abandoned |
Array
(
[id] => 5777393
[patent_doc_number] => 20060106033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Pyrazolopyridines and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 10/526839
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9870
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526839 | Pyrazolopyridines and methods of making and using the same | Sep 4, 2003 | Issued |
Array
(
[id] => 7322580
[patent_doc_number] => 20040137078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Physiologically balanced, ionized, acidic solution and methodology for use in wound healing'
[patent_app_type] => new
[patent_app_number] => 10/655493
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17939
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655493 | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing | Sep 2, 2003 | Issued |
Array
(
[id] => 7169782
[patent_doc_number] => 20040077702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Treatment of nuerodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 10/653859
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3839
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653859 | Treatment of nuerodegenerative diseases | Sep 2, 2003 | Abandoned |
Array
(
[id] => 7469768
[patent_doc_number] => 20040102473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Method of preventing or treating atherosclerosis or restenosis'
[patent_app_type] => new
[patent_app_number] => 10/651216
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15779
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102473.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651216 | Method of preventing or treating atherosclerosis or restenosis | Aug 27, 2003 | Abandoned |
Array
(
[id] => 7468884
[patent_doc_number] => 20040054005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Sodium channel blocker compositions and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/644783
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9770
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20040054005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10644783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/644783 | Sodium channel blocker compositions and the use thereof | Aug 20, 2003 | Issued |
Array
(
[id] => 7330226
[patent_doc_number] => 20040254234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Medicament for prevention and/or therapy of arterial wall disorder'
[patent_app_type] => new
[patent_app_number] => 10/643404
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4916
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643404 | Medicament for prevention and/or therapy of arterial wall disorder | Aug 17, 2003 | Issued |
Array
(
[id] => 570040
[patent_doc_number] => 07462638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Use of IκB-kinase inhibitors in pain therapy'
[patent_app_type] => utility
[patent_app_number] => 10/642974
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14971
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462638.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642974 | Use of IκB-kinase inhibitors in pain therapy | Aug 17, 2003 | Issued |
Array
(
[id] => 7169927
[patent_doc_number] => 20040077730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Medical treatment'
[patent_app_type] => new
[patent_app_number] => 10/641506
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4552
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10641506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/641506 | Medical treatment | Aug 14, 2003 | Abandoned |
Array
(
[id] => 263804
[patent_doc_number] => 07569569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Pyrrolo[2,3-d]pyrimidine compounds'
[patent_app_type] => utility
[patent_app_number] => 10/640079
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12706
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569569.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640079 | Pyrrolo[2,3-d]pyrimidine compounds | Aug 12, 2003 | Issued |